A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients With Metastatic Renal Cancer
PHASE1CompletedINTERVENTIONAL
Enrollment
46
Participants
Timeline
Start Date
February 28, 1997
Study Completion Date
January 31, 2001
Conditions
Kidney NeoplasmsNeoplasm Metastasis
Interventions
DRUG
PSC 833
DRUG
vinblastine
Trial Locations (1)
20892
National Cancer Institute (NCI), Bethesda
All Listed Sponsors
lead
National Cancer Institute (NCI)
NIH
NCT00001570 - A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients With Metastatic Renal Cancer | Biotech Hunter | Biotech Hunter